105 related articles for article (PubMed ID: 19717214)
1. Synthesis and pharmacological evaluation of novel N-alkyl/aryl substituted thiazolidinone arecoline analogues as muscarinic receptor 1 agonist in Alzheimer's dementia models.
Sadashiva CT; Chandra JN; Kavitha CV; Thimmegowda A; Subhash MN; Rangappa KS
Eur J Med Chem; 2009 Dec; 44(12):4848-54. PubMed ID: 19717214
[TBL] [Abstract][Full Text] [Related]
2. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
Malviya M; Kumar YC; Mythri RB; Venkateshappa C; Subhash MN; Rangappa KS
Bioorg Med Chem; 2009 Aug; 17(15):5526-34. PubMed ID: 19595599
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
Malviya M; Kumar YC; Asha D; Chandra JN; Subhash MN; Rangappa KS
Bioorg Med Chem; 2008 Aug; 16(15):7095-101. PubMed ID: 18640043
[TBL] [Abstract][Full Text] [Related]
5. Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer's dementia models.
Kumar YC; Malviya M; Chandra JN; Sadashiva CT; Kumar CS; Prasad SB; Prasanna DS; Subhash MN; Rangappa KS
Bioorg Med Chem; 2008 May; 16(9):5157-63. PubMed ID: 18359231
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
[TBL] [Abstract][Full Text] [Related]
7. Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.
Bromidge SM; Brown F; Cassidy F; Clark MS; Dabbs S; Hadley MS; Hawkins J; Loudon JM; Naylor CB; Orlek BS; Riley GJ
J Med Chem; 1997 Dec; 40(26):4265-80. PubMed ID: 9435896
[TBL] [Abstract][Full Text] [Related]
8. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
[TBL] [Abstract][Full Text] [Related]
9. Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials.
McArthur RA; Gray J; Schreiber R
Curr Opin Investig Drugs; 2010 Jul; 11(7):740-60. PubMed ID: 20571970
[TBL] [Abstract][Full Text] [Related]
10. Bioisosteres of arecoline: 1,2,3,6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity.
Moltzen EK; Pedersen H; Bøgesø KP; Meier E; Frederiksen K; Sánchez C; Løve Lembøl H
J Med Chem; 1994 Nov; 37(24):4085-99. PubMed ID: 7990109
[TBL] [Abstract][Full Text] [Related]
11. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Ladner CJ; Lee JM
Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
[TBL] [Abstract][Full Text] [Related]
12. AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer’s Disease.
Fisher A; Bezprozvanny I; Wu L; Ryskamp DA; Bar-Ner N; Natan N; Brandeis R; Elkon H; Nahum V; Gershonov E; LaFerla FM; Medeiros R
Neurodegener Dis; 2016; 16(1-2):95-110. PubMed ID: 26606130
[TBL] [Abstract][Full Text] [Related]
13. Aliphatic and heterocyclic analogues of arecaidine propargyl ester. Structure-activity relationships of mono- and bivalent ligands at muscarinic M1 (M4), M2 and M3 receptor subtypes.
Moser U; Gubitz C; Galvan M; Immel-Sehr A; Lambrecht G; Mutshcler E
Arzneimittelforschung; 1995 Apr; 45(4):449-55. PubMed ID: 7779140
[TBL] [Abstract][Full Text] [Related]
14. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
Sheardown MJ; Shannon HE; Swedberg MD; Suzdak PD; Bymaster FP; Olesen PH; Mitch CH; Ward JS; Sauerberg P
J Pharmacol Exp Ther; 1997 May; 281(2):868-75. PubMed ID: 9152396
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
[TBL] [Abstract][Full Text] [Related]
16. M1 muscarinic agonists target major hallmarks of Alzheimer's disease--the pivotal role of brain M1 receptors.
Fisher A
Neurodegener Dis; 2008; 5(3-4):237-40. PubMed ID: 18322400
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type.
Raffaele KC; Berardi A; Asthana S; Morris P; Haxby JV; Soncrant TT
Psychopharmacol Bull; 1991; 27(3):315-9. PubMed ID: 1775605
[TBL] [Abstract][Full Text] [Related]
18. 1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives.
Jeppesen L; Olesen PH; Hansen L; Sheardown MJ; Thomsen C; Rasmussen T; Jensen AF; Christensen MS; Rimvall K; Ward JS; Whitesitt C; Calligaro DO; Bymaster FP; Delapp NW; Felder CC; Shannon HE; Sauerberg P
J Med Chem; 1999 Jun; 42(11):1999-2006. PubMed ID: 10354408
[TBL] [Abstract][Full Text] [Related]
19. Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activity.
Sauerberg P; Olesen PH; Sheardown MJ; Rimvall K; Thøgersen H; Shannon HE; Sawyer BD; Ward JS; Bymaster FP; DeLapp NW; Calligaro DO; Swedberg MD
J Med Chem; 1998 Jan; 41(1):109-16. PubMed ID: 9438027
[TBL] [Abstract][Full Text] [Related]
20. [Selective M1 muscarinic agonists: failure of therapeutic strategy against Alzheimer's disease or inappropriate tactics?].
Vamvakidès A
Ann Pharm Fr; 2003 May; 61(3):207-10. PubMed ID: 12714934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
